
C21 Investments Announces Renewed Normal Course Issuer Bid
Vancouver, British Columbia--(Newsfile Corp. - December 5, 2025) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, is pleased to announce that it intends to commence a renewed normal course issuer bid (the "NCIB"), under which it may purchase up to 5,898,596 common shares of the Company ("Common Shares"), representing approximately 5% of the Company's issued and outstanding Common Shares. The Company may purchase Common Shares under the NCIB over a 12-month period beginning on December 9, 2025 and ending on December 9, 2026.













